Clindabactin

1 x 10 pc

Chewable tablet

Active substance

Clindamycin (Clindamycin hydrochloride) : 440 mg

ATC code

QJ01FF01 Clindamycin

QJ01FF Lincosamides

QJ01F Macrolides, lincosamides and streptogramins

QJ01 Antibacterials for systemic use

QJ Antiinfectives for systemic use

Species

Dogs.

Indications

For the treatment of infected wounds and abscesses, and oral cavity infections including periodontal disease, caused by or associated with Staphylococcus spp., Streptococcus spp. (except Streptococcus faecalis), Bacteroides spp., Fusobacterium necrophorum, and Clostridium perfringens susceptible to clindamycin.

For the treatment of superficial pyoderma associated with Staphylococcus pseudintermedius susceptible to clindamycin.

For the treatment of osteomyelitis, caused by Staphylococcus aureus susceptible to clindamycin.

Dose to be administered and administration route

Oral use.

1. For the treatment of infected wounds and abscesses, and oral cavity infections including periodontal disease, administer either:

• 5.5 mg clindamycin/kg bodyweight every 12 hours for 7-10 days, or • 11 mg clindamycin/kg bodyweight every 24 hours for 7-10 days If no clinical response is seen within 4 days, redetermine the diagnosis.

2. For the treatment of superficial pyoderma, administer either:

• 5.5 mg clindamycin/kg bodyweight every 12 hours, or

• 11 mg clindamycin/kg bodyweight every 24 hours

Therapy of canine superficial pyoderma is usually recommended for 21 days, with shortening or extension of therapy based on clinical judgement.

3. For the treatment of osteomyelitis, administer:

• 11 mg clindamycin/kg bodyweight every 12 hours for a minimum of 28 days If no clinical response is seen within 14 days, the treatment should be stopped and the diagnosis redetermined.

To ensure a correct dosage, bodyweight should be determined as accurately as possible to avoid under-dosing.

Tablets can be divided into 2 or 4 equal parts to ensure accurate dosing. Place the tablet on a flat surface, with its scored side facing up and the convex (rounded) side facing the surface.

2 equal parts: press down with your thumbs on both sides of the tablet. 4 equal parts: press down with your thumb in the middle of the tablet.

Adverse reactions

Dogs:

Uncommon

(1 to 10 animals / 1,000 animals treated):

Vomiting, diarrhoea, disorder of gastrointestinal flora^a

^a Clindamycin causes overgrowth of non-sensitive organisms such as resistant clostridia and yeasts. In cases of superinfection, appropriate measures must be taken according to the clinical situation.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.